Annual report
9265.TEDINET S100YXFY
Period2025-06-01 → 2026-05-31
Filed2026-08-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥64.1bn | 2025-06-01 → 2026-05-31 | Cons. | Net sales |
| Revenue | ¥64.5bn | 2024-06-01 → 2025-05-31 | Cons. | Net sales |
| Revenue | ¥61.6bn | 2023-06-01 → 2024-05-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥58.2bn | 2022-06-01 → 2023-05-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥55.1bn | 2021-06-01 → 2022-05-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥737m | 2025-06-01 → 2026-05-31 | Cons. | Operating income |
| Operating income | ¥838m | 2024-06-01 → 2025-05-31 | Cons. | Operating income |
| Ordinary income | ¥877m | 2025-06-01 → 2026-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥909m | 2024-06-01 → 2025-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.0bn | 2023-06-01 → 2024-05-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.2bn | 2022-06-01 → 2023-05-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.0bn | 2021-06-01 → 2022-05-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥929m | 2025-06-01 → 2026-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥943m | 2024-06-01 → 2025-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥648m | 2025-06-01 → 2026-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥616m | 2024-06-01 → 2025-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥580m | 2023-06-01 → 2024-05-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥219m | 2022-06-01 → 2023-05-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥696m | 2021-06-01 → 2022-05-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥647m | 2025-06-01 → 2026-05-31 | Cons. | Profit loss |
| Net income | ¥614m | 2024-06-01 → 2025-05-31 | Cons. | Profit loss |
| Total assets | ¥27.1bn | at 2026-05-31 | Cons. | Assets |
| Total assets | ¥27.5bn | at 2025-05-31 | Cons. | Assets |
| Total assets | ¥26.6bn | at 2024-05-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥24.6bn | at 2023-05-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥24.1bn | at 2022-05-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥17.7bn | at 2026-05-31 | Cons. | Liabilities |
| Total liabilities | ¥18.6bn | at 2025-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥9.4bn | at 2026-05-31 | Cons. | Net assets |
| Net assets / equity | ¥9.0bn | at 2025-05-31 | Cons. | Net assets |
| Net assets / equity | ¥8.6bn | at 2024-05-31v | Cons. | Net assets |
| Net assets / equity | ¥7.9bn | at 2023-05-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥8.0bn | at 2022-05-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥4.1bn | at 2026-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.7bn | at 2025-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥4.1bn | at 2026-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.7bn | at 2025-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.3bn | at 2024-05-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.8bn | at 2023-05-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥4.0bn | at 2022-05-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥88m | 2025-06-01 → 2026-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥617m | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥878m | 2023-06-01 → 2024-05-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.2bn | 2022-06-01 → 2023-05-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥581m | 2021-06-01 → 2022-05-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥1.3bn | 2025-06-01 → 2026-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥19m | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.1bn | 2023-06-01 → 2024-05-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥107m | 2022-06-01 → 2023-05-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥27m | 2021-06-01 → 2022-05-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥337m | 2025-06-01 → 2026-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥240m | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥335m | 2023-06-01 → 2024-05-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥209m | 2022-06-01 → 2023-05-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥229m | 2021-06-01 → 2022-05-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥258.56 | 2025-06-01 → 2026-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥249.79 | 2024-06-01 → 2025-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥227.96 | 2023-06-01 → 2024-05-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥85.83 | 2022-06-01 → 2023-05-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥272.67 | 2021-06-01 → 2022-05-31v | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥3,680.48 | at 2026-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,640.22 | at 2025-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,429.08 | at 2024-05-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,097.34 | at 2023-05-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,126.18 | at 2022-05-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 34.6% | at 2026-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.6% | at 2025-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.2% | at 2024-05-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.2% | at 2023-05-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.1% | at 2022-05-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 7.1% | 2025-06-01 → 2026-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.0% | 2024-06-01 → 2025-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.1% | 2023-06-01 → 2024-05-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 2.8% | 2022-06-01 → 2023-05-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.9% | 2021-06-01 → 2022-05-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 617 | at 2026-05-31 | Cons. | Number of employees |
| Employees | 613 | at 2025-05-31 | Cons. | Number of employees |
| Employees | 606 | at 2024-05-31v | Cons. | Number of employees |
| Employees | 570 | at 2023-05-31v | Cons. | Number of employees |
| Employees | 574 | at 2022-05-31v | Cons. | Number of employees |
| Revenue | ¥1.5bn | 2025-06-01 → 2026-05-31 | Standalone | Operating revenue1 |
| Revenue | ¥1.4bn | 2024-06-01 → 2025-05-31 | Standalone | Operating revenue1 |
| Revenue | ¥1.4bn | 2023-06-01 → 2024-05-31v | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥498m | 2022-06-01 → 2023-05-31v | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥792m | 2021-06-01 → 2022-05-31v | Standalone | Operating revenue1 (5-year summary) |
| Operating income | ¥809m | 2025-06-01 → 2026-05-31 | Standalone | Operating income |
| Operating income | ¥729m | 2024-06-01 → 2025-05-31 | Standalone | Operating income |
| Ordinary income | ¥819m | 2025-06-01 → 2026-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥728m | 2024-06-01 → 2025-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥764m | 2023-06-01 → 2024-05-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥16m | 2022-06-01 → 2023-05-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥227m | 2021-06-01 → 2022-05-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥754m | 2025-06-01 → 2026-05-31 | Standalone | Income before income taxes |
| Profit before tax | ¥728m | 2024-06-01 → 2025-05-31 | Standalone | Income before income taxes |
| Net income | ¥740m | 2025-06-01 → 2026-05-31 | Standalone | Profit loss |
| Net income | ¥718m | 2024-06-01 → 2025-05-31 | Standalone | Profit loss |
| Net income | ¥767m | 2023-06-01 → 2024-05-31v | Standalone | Net income loss (5-year summary) |
| Net income | −¥13m | 2022-06-01 → 2023-05-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥228m | 2021-06-01 → 2022-05-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥8.8bn | at 2026-05-31 | Standalone | Assets |
| Total assets | ¥8.5bn | at 2025-05-31 | Standalone | Assets |
| Total assets | ¥8.0bn | at 2024-05-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥6.3bn | at 2023-05-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥6.5bn | at 2022-05-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.3bn | at 2026-05-31 | Standalone | Liabilities |
| Total liabilities | ¥1.8bn | at 2025-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥7.5bn | at 2026-05-31 | Standalone | Net assets |
| Net assets / equity | ¥6.8bn | at 2025-05-31 | Standalone | Net assets |
| Net assets / equity | ¥6.3bn | at 2024-05-31v | Standalone | Net assets |
| Net assets / equity | ¥5.8bn | at 2023-05-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥6.0bn | at 2022-05-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥328m | at 2026-05-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥732m | at 2025-05-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥295.55 | 2025-06-01 → 2026-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥291.15 | 2024-06-01 → 2025-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥301.31 | 2023-06-01 → 2024-05-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.29 | 2022-06-01 → 2023-05-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥89.32 | 2021-06-01 → 2022-05-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥107 | 2025-06-01 → 2026-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥75 | 2024-06-01 → 2025-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥70 | 2023-06-01 → 2024-05-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥48 | 2022-06-01 → 2023-05-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥82 | 2021-06-01 → 2022-05-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,954.65 | at 2026-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,741.18 | at 2025-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,521.27 | at 2024-05-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,272.88 | at 2023-05-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,360.07 | at 2022-05-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 85.2% | at 2026-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.2% | at 2025-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.2% | at 2024-05-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.2% | at 2023-05-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.4% | at 2022-05-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 10.4% | 2025-06-01 → 2026-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.0% | 2024-06-01 → 2025-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.7% | 2023-06-01 → 2024-05-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | -0.2% | 2022-06-01 → 2023-05-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.8% | 2021-06-01 → 2022-05-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 2,553,000 | at 2026-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,553,000 | at 2025-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,553,000 | at 2024-05-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,553,000 | at 2023-05-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,553,000 | at 2022-05-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 31 | at 2026-05-31 | Standalone | Number of employees |
| Employees | 30 | at 2025-05-31 | Standalone | Number of employees |
| Employees | 29 | at 2024-05-31v | Standalone | Number of employees |
| Employees | 30 | at 2023-05-31v | Standalone | Number of employees |
| Employees | 27 | at 2022-05-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 48
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | depreciation | 2025-06-01 → 2026-05-31 | ¥37m |
| Reconciling Itemsreconciling | revenue | 2025-06-01 → 2026-05-31 | −¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-06-01 → 2026-05-31 | −¥2m |
| Reconciling Itemsreconciling | segment profit | 2025-06-01 → 2026-05-31 | −¥1.2bn |
| Medical Equipment Manufacturing And Salesreportable segment | depreciation | 2025-06-01 → 2026-05-31 | ¥45m |
| Medical Equipment Manufacturing And Salesreportable segment | employees | at 2026-05-31 | 9 pure |
| Medical Equipment Manufacturing And Salesreportable segment | revenue | 2025-06-01 → 2026-05-31 | ¥210m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2025-06-01 → 2026-05-31 | ¥207m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2025-06-01 → 2026-05-31 | ¥2m |
| Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2025-06-01 → 2026-05-31 | −¥185m |
| Medical Equipment Salesreportable segment | depreciation | 2025-06-01 → 2026-05-31 | ¥117m |
| Medical Equipment Salesreportable segment | employees | at 2026-05-31 | 564 pure |
| Medical Equipment Salesreportable segment | revenue | 2025-06-01 → 2026-05-31 | ¥63.9bn |
| Medical Equipment Salesreportable segment | revenue external | 2025-06-01 → 2026-05-31 | ¥63.9bn |
| Medical Equipment Salesreportable segment | revenue intersegment | 2025-06-01 → 2026-05-31 | ¥0 |
| Medical Equipment Salesreportable segment | segment profit | 2025-06-01 → 2026-05-31 | ¥2.1bn |
| Medical Mallreportable segment | depreciation | 2025-06-01 → 2026-05-31 | ¥14m |
| Medical Mallreportable segment | revenue | 2025-06-01 → 2026-05-31 | ¥74m |
| Medical Mallreportable segment | revenue external | 2025-06-01 → 2026-05-31 | ¥74m |
| Medical Mallreportable segment | segment profit | 2025-06-01 → 2026-05-31 | ¥7m |
| —segment total | depreciation | 2025-06-01 → 2026-05-31 | ¥177m |
| —segment total | revenue | 2025-06-01 → 2026-05-31 | ¥64.2bn |
| —segment total | revenue external | 2025-06-01 → 2026-05-31 | ¥64.1bn |
| —segment total | revenue intersegment | 2025-06-01 → 2026-05-31 | ¥2m |
| —segment total | segment profit | 2025-06-01 → 2026-05-31 | ¥2.0bn |
| Reconciling Itemsreconciling | depreciation | 2024-06-01 → 2025-05-31 | ¥37m |
| Reconciling Itemsreconciling | revenue | 2024-06-01 → 2025-05-31 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2024-06-01 → 2025-05-31 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2024-06-01 → 2025-05-31 | −¥1.1bn |
| Medical Equipment Manufacturing And Salesreportable segment | depreciation | 2024-06-01 → 2025-05-31 | ¥6m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue | 2024-06-01 → 2025-05-31 | ¥219m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2024-06-01 → 2025-05-31 | ¥219m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2024-06-01 → 2025-05-31 | ¥0 |
| Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2024-06-01 → 2025-05-31 | −¥220m |
| Medical Equipment Salesreportable segment | depreciation | 2024-06-01 → 2025-05-31 | ¥122m |
| Medical Equipment Salesreportable segment | revenue | 2024-06-01 → 2025-05-31 | ¥64.2bn |
| Medical Equipment Salesreportable segment | revenue external | 2024-06-01 → 2025-05-31 | ¥64.2bn |
| Medical Equipment Salesreportable segment | revenue intersegment | 2024-06-01 → 2025-05-31 | ¥0 |
| Medical Equipment Salesreportable segment | segment profit | 2024-06-01 → 2025-05-31 | ¥2.2bn |
| Medical Mallreportable segment | depreciation | 2024-06-01 → 2025-05-31 | ¥14m |
| Medical Mallreportable segment | revenue | 2024-06-01 → 2025-05-31 | ¥72m |
| Medical Mallreportable segment | revenue external | 2024-06-01 → 2025-05-31 | ¥72m |
| Medical Mallreportable segment | segment profit | 2024-06-01 → 2025-05-31 | ¥5m |
| —segment total | depreciation | 2024-06-01 → 2025-05-31 | ¥143m |
| —segment total | revenue | 2024-06-01 → 2025-05-31 | ¥64.5bn |
| —segment total | revenue external | 2024-06-01 → 2025-05-31 | ¥64.5bn |
| —segment total | revenue intersegment | 2024-06-01 → 2025-05-31 | ¥0 |
| —segment total | segment profit | 2024-06-01 → 2025-05-31 | ¥2.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,495
| Item | Context | Value | Unit |
|---|---|---|---|
| Freightage expenses sga | Prior1YearDuration | 366000000 | JPY |
| Freightage expenses sga | CurrentYearDuration | 377000000 | JPY |
| Supplies expenses sga | Prior1YearDuration | 91000000 | JPY |
| Supplies expenses sga | CurrentYearDuration | 123000000 | JPY |
| Rents sga | Prior1YearDuration | 396000000 | JPY |
| Rents sga | CurrentYearDuration | 399000000 | JPY |
| Commission fee sga | Prior1YearDuration | 299000000 | JPY |
| Commission fee sga | CurrentYearDuration | 375000000 | JPY |
| Depreciation sga | Prior1YearDuration | 165000000 | JPY |
| Depreciation sga | CurrentYearDuration | 200000000 | JPY |
| Amortization of goodwill sga | Prior1YearDuration | 45000000 | JPY |
| Amortization of goodwill sga | CurrentYearDuration | 45000000 | JPY |
| Other sga | Prior1YearDuration | 967000000 | JPY |
| Other sga | CurrentYearDuration | 889000000 | JPY |
| Selling general and administrative expenses | Prior1YearDuration | 7938000000 | JPY |
| Selling general and administrative expenses | CurrentYearDuration | 8062000000 | JPY |
| Operating income | Prior1YearDuration | 838000000 | JPY |
| Operating income | CurrentYearDuration | 737000000 | JPY |
| Interest and dividends income noi | Prior1YearDuration | 12000000 | JPY |
| Interest and dividends income noi | CurrentYearDuration | 15000000 | JPY |
| Purchase discounts noi | Prior1YearDuration | 15000000 | JPY |
| Purchase discounts noi | CurrentYearDuration | 15000000 | JPY |
| Commission fee noi | Prior1YearDuration | 26000000 | JPY |
| Commission fee noi | CurrentYearDuration | 28000000 | JPY |
| Insurance premiums refunded cancellation noi | Prior1YearDuration | － | JPY |
| Insurance premiums refunded cancellation noi | CurrentYearDuration | 53000000 | JPY |
| Consumption tax difference noi | Prior1YearDuration | 0 | JPY |
| Consumption tax difference noi | CurrentYearDuration | 42000000 | JPY |
| Other noi | Prior1YearDuration | 41000000 | JPY |
| Other noi | CurrentYearDuration | 25000000 | JPY |
| Non operating income | Prior1YearDuration | 96000000 | JPY |
| Non operating income | CurrentYearDuration | 181000000 | JPY |
| Interest expenses noe | Prior1YearDuration | 6000000 | JPY |
| Interest expenses noe | CurrentYearDuration | 6000000 | JPY |
| Foreign exchange losses noe | Prior1YearDuration | － | JPY |
| Foreign exchange losses noe | CurrentYearDuration | 10000000 | JPY |
| Equity in losses of affiliates noe | Prior1YearDuration | 1000000 | JPY |
| Equity in losses of affiliates noe | CurrentYearDuration | － | JPY |
| Loss on sales of notes payable noe | Prior1YearDuration | 10000000 | JPY |
| Loss on sales of notes payable noe | CurrentYearDuration | 11000000 | JPY |
| Expense related to restricted stock noe | Prior1YearDuration | － | JPY |
| Expense related to restricted stock noe | CurrentYearDuration | 5000000 | JPY |
| Other noe | Prior1YearDuration | 7000000 | JPY |
| Other noe | CurrentYearDuration | 7000000 | JPY |
| Non operating expenses | Prior1YearDuration | 25000000 | JPY |
| Non operating expenses | CurrentYearDuration | 41000000 | JPY |
| Ordinary income | Prior1YearDuration | 909000000 | JPY |
| Ordinary income | CurrentYearDuration | 877000000 | JPY |
| Reversal of allowance for doubtful accounts ei | Prior1YearDuration | 36000000 | JPY |
| Reversal of allowance for doubtful accounts ei | CurrentYearDuration | 50000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |